JNJ
Johnson & Johnson
- Net income, FY2025
- $26.8B
- YoY, FY2025
- +90.6%
- 5-year CAGR
- +12.7%
- 10-year CAGR
- +5.7%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| FY2025 | $26.8B | +90.6% |
| FY2024 | $14.1B | −60.0% |
| FY2023 | $35.2B | +95.9% |
| FY2022 | $17.9B | −14.1% |
| FY2021 | $20.9B | +41.9% |
| FY2020 | $14.7B | −2.7% |
| FY2019 | $15.1B | −1.2% |
| FY2018 | $15.3B | +1,076.7% |
| FY2017 | $1.3B | −92.1% |
| FY2016 | $16.5B | +7.3% |
| FY2015 | $15.4B | −5.6% |
| FY2014 | $16.3B | +18.0% |
| FY2013 | $13.8B | +27.4% |
| FY2012 | $10.9B | +12.2% |
| FY2011 | $9.7B | −27.5% |
| FY2010 | $13.3B | +8.7% |
| FY2009 | $12.3B | −5.3% |
| FY2008 | $12.9B | +22.4% |
| FY2007 | $10.6B | — |